Benign Prostatic Hyperplasia
Information
- Disease name
- Benign Prostatic Hyperplasia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04386941 | Active, not recruiting | N/A | Greenlight Vaporization vs Xpeeda Vaporesection | July 31, 2019 | July 31, 2024 |
| NCT06051383 | Active, not recruiting | N/A | Outcome of Conducting Self-management Intervention on Severity of Lower Urinary Tract Symptoms | June 1, 2023 | July 1, 2024 |
| NCT03758222 | Active, not recruiting | N/A | Safety and Feasibility of the XFLO Expander System (Mercury) | November 7, 2018 | August 2025 |
| NCT03350529 | Active, not recruiting | N/A | MRI Guided Transurethral HIFU for Various Prostate Diseases | July 24, 2017 | December 2024 |
| NCT05982444 | Active, not recruiting | N/A | Long Term Follow up of Water Vapor Thermal Therapy (Rezum) for Benign Prostatic Hyperplasia (BPH) | January 1, 2020 | December 2023 |
| NCT04131907 | Active, not recruiting | N/A | A Clinical Study to Evaluate the Safety and Efficacy of the Optilume™ BPH Catheter System in Men With Symptomatic BPH | February 5, 2020 | May 2027 |
| NCT05494567 | Active, not recruiting | Phase 4 | Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OAB | November 8, 2021 | August 2022 |
| NCT04391114 | Active, not recruiting | N/A | Top-Down Holmium Laser Enucleation of the Prostate (HoLEP) vs the Traditional HoLEP for Treatment of Benign Prostatic Hyperplasia (BPH) | October 15, 2019 | December 31, 2024 |
| NCT00159406 | Active, not recruiting | Laser Prostatectomy Database and Registry | October 2003 | December 2025 | |
| NCT03423979 | Active, not recruiting | Phase 2 | Optilume™ BPH Prostatic Drug Coated Balloon Dilation Catheter | December 19, 2017 | March 30, 2024 |
| NCT00199550 | Completed | Phase 4 | Bipolar vs Monopolar Transurethral Resection of the Prostate (TURP) | May 2004 | June 2008 |
| NCT00224120 | Completed | Phase 3 | A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo | May 2005 | May 2006 |
| NCT00224133 | Completed | Phase 3 | The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months | September 2005 | April 2007 |
| NCT06263049 | Completed | N/A | Is Ejaculation Preservation TURis the Natural Evolution of the "Gold Standard". | May 1, 2023 | February 1, 2024 |
| NCT06260917 | Completed | The Effect of Urinating Through the Zipper or by Pulling Down the Trousers on Uroflowmetry Parameters in LUTS | November 1, 2023 | December 31, 2023 | |
| NCT00284518 | Completed | Phase 2 | Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic Hyperplasia | December 2005 | May 2010 |
| NCT00347061 | Completed | Phase 3 | Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH | May 2006 | October 2007 |
| NCT00359905 | Completed | Phase 3 | Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH | May 2006 | January 2008 |
| NCT00364585 | Completed | Phase 4 | A Prospective Evaluation of the GreenLight Model 120 Laser | May 2006 | April 2007 |
| NCT00375765 | Completed | Phase 4 | Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer | April 2005 | July 2007 |
| NCT00379067 | Completed | Phase 4 | A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding. | October 2005 | November 2006 |
| NCT00384930 | Completed | Phase 2/Phase 3 | Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia | August 2006 | October 2008 |
| NCT00386009 | Completed | Phase 2 | Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia | October 2006 | May 2008 |
| NCT00409357 | Completed | Phase 2 | Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia | November 2004 | August 2005 |
| NCT05803096 | Completed | Phase 4 | Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain | December 12, 2021 | September 9, 2022 |
| NCT05531344 | Completed | Phase 2/Phase 3 | Composite Steep-pulseTreatment Device Used in Patients With Benign Prostatic Hyperplasia | August 20, 2020 | July 8, 2022 |
| NCT05494944 | Completed | N/A | Low Power ThULEP for Prostate Size More Than 80 gm | December 1, 2019 | March 30, 2022 |
| NCT00451191 | Completed | Phase 2 | Botulinum Toxin Injection for the Management of BPH | October 2006 | December 2009 |
| NCT00465101 | Completed | Phase 4 | A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization | May 2007 | January 2013 |
| NCT00472251 | Completed | One-year Prospective Observational Study of BMI Change Effect of 5-alpha Reductase Inhibitor in Korean BPH Patients | May 2006 | December 2008 | |
| NCT05422677 | Completed | An Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia | July 15, 2019 | August 24, 2021 | |
| NCT00527371 | Completed | N/A | PVP Compared to TURP for the Treatment of Benign Hyperplasia of the Prostate | January 2008 | October 2013 |
| NCT00527605 | Completed | Phase 3 | Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH) | October 2007 | March 2009 |
| NCT00540124 | Completed | Phase 2 | Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men | October 2007 | June 2008 |
| NCT00540891 | Completed | Phase 3 | The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score | February 2003 | October 2004 |
| NCT05416606 | Completed | N/A | Prostate Bipolar Enucleation and Resection Versus Open Prostatectomy | October 1, 2020 | June 1, 2022 |
| NCT00593593 | Completed | Pharmacovigilance Study To Evaluate Safety Of AVODART In Subjects With Benign Prostate Hyperplasia | December 2004 | ||
| NCT00637715 | Completed | Phase 4 | Once Daily Given Alfuzosin in the Treatment of BPH | October 2003 | December 2004 |
| NCT00645034 | Completed | Phase 2 | A Study to Investigate the Effects on Blood Pressure and Pulse Rate of a Single 100mg Dose of Sildenafil in Patients With Benign Prostatic Hyperplasia Who Are Being Treated With Doxazosin | November 2002 | July 2003 |
| NCT00657839 | Completed | Phase 2 | Assessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic Hyperplasia | October 2005 | June 2006 |
| NCT00662350 | Completed | Temperature Mapping of the Prostate With the Wallterm™ System | June 2008 | August 2009 | |
| NCT00680680 | Completed | N/A | Treatment of Refractory Urinary Retention Secondary to Benign Prostatic Hyperplasia (BPH) With Dual Five Alpha Reductase Inhibition Combined With an Alpha Blocker | May 2004 | February 2008 |
| NCT05222841 | Completed | Phase 2/Phase 3 | The Effectiveness of Spermotrend Food Supplement in the Treatment of Male Infertility | June 15, 2021 | December 15, 2022 |
| NCT00701779 | Completed | Phase 4 | Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia | September 2005 | July 2009 |
| NCT00709488 | Completed | Phase 1 | Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) | June 2008 | April 2011 |
| NCT00730418 | Completed | N/A | Effects of Chronic Use of Doxazosin in Men With Benign Prostatic Hyperplasia | January 2007 | March 2010 |
| NCT00771394 | Completed | Phase 4 | Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia | October 2008 | January 2010 |
| NCT00783094 | Completed | Phase 2 | Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label Extension | November 2008 | April 2010 |
| NCT00797394 | Completed | Phase 2 | Efficacy of Natural Extract 2007RD01 Combined With Saw Palmetto in Benign Prostatic Hyperplasia Patients Compared to Saw Palmetto | November 2008 | |
| NCT00827242 | Completed | Phase 3 | Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil Daily | January 2009 | November 2009 |
| NCT00827814 | Completed | Phase 4 | Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction | June 2006 | April 2009 |
| NCT00836823 | Completed | Phase 4 | Evaluation of Symptom-specific Goal Achievement | December 2005 | August 2008 |
| NCT00848081 | Completed | Phase 3 | A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers | March 2009 | December 2009 |
| NCT00855582 | Completed | Phase 3 | A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia | March 2009 | July 2010 |
| NCT00861757 | Completed | Phase 3 | Multinational Study to Evaluate Tadalafil in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia | March 2009 | June 2010 |
| NCT00877669 | Completed | Phase 2 | Efficacy Study of HoLEP and TURP on LUTS Secondary to BPH | October 2008 | December 2016 |
| NCT00880672 | Completed | Phase 4 | Effect of Dutasteride on HIF-1alpha and VEGF in the Prostate | January 2008 | April 2009 |
| NCT00889707 | Completed | Phase 2 | Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperplasia | January 2009 | September 2010 |
| NCT00890851 | Completed | N/A | Procedure Transurethral Needle Ablation (TUNA) and Hospitalization of Short Duration | March 2006 | March 2009 |
| NCT00894517 | Completed | Phase 1/Phase 2 | A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia | August 2009 | August 2012 |
| NCT00908427 | Completed | N/A | Impact of 80 W KTP Laser Vaporization Prostatectomy on Severity of Obstruction in Benign Prostatic Hyperplasia | June 2004 | September 2007 |
| NCT00918034 | Completed | Phase 2 | Study of Light-Activated Talaporfin Sodium in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) | May 2009 | February 2011 |
| NCT00918983 | Completed | Phase 3 | Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) | April 2009 | November 2013 |
| NCT00922506 | Completed | Phase 4 | Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH) | May 2009 | June 2014 |
| NCT05027971 | Completed | Flexiva Pulse Registry | November 1, 2021 | October 31, 2023 | |
| NCT00962390 | Completed | Phase 2 | Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia | June 2009 | January 2016 |
| NCT00969072 | Completed | Phase 2 | Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia | August 2003 | February 2005 |
| NCT01002222 | Completed | Phase 3 | Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c) | January 2011 | February 2014 |
| NCT01002274 | Completed | Phase 3 | Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms | August 2010 | June 2014 |
| NCT01002417 | Completed | Phase 2/Phase 3 | MCS in the Treatment of Lower Urinary Tract Symptoms | July 2010 | February 2014 |
| NCT01002664 | Completed | Phase 3 | Efficacy and Safety of MCS-2 in the Treatment of Lower Urinary Tract Symptoms | May 2010 | June 2014 |
| NCT01018511 | Completed | Phase 3 | Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms | January 2010 | March 2011 |
| NCT01021332 | Completed | Phase 3 | Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms | April 26, 2010 | December 14, 2011 |
| NCT01043588 | Completed | N/A | TRP Versus Photo Selective Vaporization for Obstructive Benign Prostatic Hyperplasia Management | November 2007 | February 2011 |
| NCT04962269 | Completed | Application of DWI in Diagnosis of Prostate Cancer | June 12, 2013 | June 21, 2018 | |
| NCT04947631 | Completed | Phase 3 | Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia | July 27, 2021 | June 12, 2023 |
| NCT01107392 | Completed | Phase 2 | Safety and Efficacy of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia | August 1, 2010 | June 8, 2012 |
| NCT01139762 | Completed | Phase 3 | A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms | September 2010 | May 2012 |
| NCT01152190 | Completed | Phase 3 | A Study in Benign Prostatic Hyperplasia | September 2010 | July 2012 |
| NCT01183650 | Completed | Phase 1 | A Study of Tadalafil in Benign Prostatic Hyperplasia | July 2010 | April 2011 |
| NCT01218672 | Completed | N/A | Photoselective Vaporization of the Prostate With the GreenLight XPS™ Laser System vs TURP for the Treatment of BPH | April 2011 | December 2014 |
| NCT01250483 | Completed | Effects of Alpha Blockers on Prostate-specific Antigen (PSA) Change in Men With Lower Urinary Tract Symptoms (LUTS) | January 2001 | December 2009 | |
| NCT01259531 | Completed | Phase 4 | Study of a α1A Adrenoceptor Selective Antagonist Silodosin to Treat Severe Benign Prostatic Hyperplasia(BPH) | December 2010 | September 2011 |
| NCT01294150 | Completed | N/A | The Safety and Effectiveness of UroLift: LIFT Pivotal Study | February 2011 | July 5, 2017 |
| NCT01299571 | Completed | AVODART(Dutasteride) Post-marketing Surveillance(PMS) | December 2004 | July 2010 | |
| NCT01301599 | Completed | Phase 4 | Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH) | January 2011 | December 2013 |
| NCT04856943 | Completed | N/A | Effectiveness of Smartconsent in Improving Understanding of Informed Consent | December 31, 2021 | December 31, 2021 |
| NCT01337258 | Completed | Economic Analyses of the REDUCE Trial | January 2010 | July 2010 | |
| NCT04831476 | Completed | Α Prospective Observational Study for the Evaluation of Disease Control and Quality of Life in Patients With Benign PROStatic hyPERplasia Under Fixed Dose combΙnaTion Treatment With Dutasteride and Tamsulosin . PROSPERITY Group of Studies (I&II) | September 1, 2021 | October 31, 2022 | |
| NCT01371513 | Completed | Korean Practice Patterns for Screening PCA(Prostate Cancer) | May 2010 | June 2011 | |
| NCT01387893 | Completed | N/A | A Self-Administered Maneuver to Relieve Symptoms Suggestive of Benign Prostatic Hyperplasia | May 2008 | November 2009 |
| NCT04781049 | Completed | N/A | Transperineal Laser Ablation vs Transurethral Resection for Benign Prostatic Obstruction: A Randomized Clinical Trial | January 1, 2021 | October 6, 2022 |
| NCT01435954 | Completed | Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy | August 2010 | March 2011 | |
| NCT01438775 | Completed | Phase 3 | Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) | September 2011 | January 2013 |
| NCT01454349 | Completed | Phase 1/Phase 2 | Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH) | September 2011 | August 2013 |
| NCT01460342 | Completed | Phase 3 | Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH) | December 2011 | October 2012 |
| NCT04471155 | Completed | N/A | Comparison of Holmium Laser Enucleation Prostatectomy and Open Transvesical Prostatectomy in Large Prostate | April 1, 2018 | April 22, 2020 |
| NCT01533038 | Completed | N/A | BPH-6: Comparison of the UroLift System to TURP for Benign Prostatic Hyperplasia | February 2012 | January 2016 |
| NCT04446429 | Completed | N/A | Anti-Androgen Treatment for COVID-19 | October 21, 2020 | January 21, 2021 |
| NCT01534793 | Completed | QUAPELLA (QUAlity of Prostate Enucleation by LUMENIS - Laser) | February 2012 | July 2014 | |
| NCT01589263 | Completed | Phase 2 | Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With BPH and LUTS | June 1, 2012 | September 30, 2019 |
| NCT01604148 | Completed | Retrospective Review a Comprehensive Case Database of HoLEP Procedure Performed by a Single Surgeon | July 2011 | July 2011 | |
| NCT01678313 | Completed | Phase 2 | Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels | August 2012 | August 2013 |
| NCT01716104 | Completed | Phase 3 | Clinical Trial of Safety and Efficacy of Afalaza in Patients With Symptoms of Benign Prostatic Hyperplasia and Risk of Progression | November 2012 | November 2016 |
| NCT01757769 | Completed | Phase 4 | Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia | May 2011 | August 2013 |
| NCT01826617 | Completed | Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy Outcome | December 2010 | December 2014 | |
| NCT01846793 | Completed | Phase 3 | Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022) | April 2013 | October 2014 |
| NCT01876706 | Completed | N/A | UroLift System TOlerability and ReCovery When Administering Local Anesthesia | April 2013 | September 4, 2018 |
| NCT01886547 | Completed | 2013 Annual National Digital Rectal Exam (DRE) Day Study | June 2013 | October 2014 | |
| NCT01912339 | Completed | N/A | Safety and Efficacy Study for the Treatment of BPH (Enlarged Prostate) | July 2013 | October 17, 2016 |
| NCT01924988 | Completed | Phase 1/Phase 2 | Prostate Embolization for Benign Prostatic Hyperplasia | August 2013 | April 2017 |
| NCT04308070 | Completed | N/A | Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia III | July 18, 2017 | June 30, 2018 |
| NCT01939184 | Completed | Phase 2 | Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia | August 2013 | April 2014 |
| NCT01958892 | Completed | To Compare Outcomes After Transurethral Enucleation of Prostate Versus Transurethral Resection of Prostate | |||
| NCT01963312 | Completed | N/A | Clinical Trial to Evaluate the Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate to Treat the Urinary Symptoms. | March 2014 | May 2018 |
| NCT01966614 | Completed | Phase 3 | Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH | October 2013 | December 2015 |
| NCT04272216 | Completed | An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres | February 6, 2020 | March 11, 2023 | |
| NCT04271020 | Completed | N/A | Urodynamic Feasibility Study Utilizing the UroLift® System | October 25, 2018 | November 27, 2019 |
| NCT02029560 | Completed | Observational Study to Evaluate Effect of Thrupas® Capsule on Cardiovascular System | November 2013 | November 2014 | |
| NCT02051036 | Completed | N/A | Moxibustion as an Adjuvant for Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms: a Pilot Study | February 2014 | December 2015 |
| NCT02054013 | Completed | N/A | Prostatic Artery Embolization vs. Conventional Transurethral Prostatectomy in the Treatment of Benign Prostatic Hyperplasia | February 11, 2014 | July 16, 2022 |
| NCT02106182 | Completed | Phase 4 | Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia | January 2, 2014 | August 1, 2016 |
| NCT02139969 | Completed | GreenLight XPS Laser System Retrospective Chart Review | May 2014 | November 2014 | |
| NCT04263987 | Completed | Phase 3 | A Comparison of Traditional and MOSES Laser Enucleation of the Prostate (MOLEP): A Prospective, Randomized, Double-blinded Control Trial A Comparison of Traditional and MOSES Laser Enucleation of the Prostate (MOLEP): A Prospective, Randomized, Double-blinded Control Trial | January 1, 2020 | December 30, 2020 |
| NCT02167919 | Completed | N/A | Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH) | July 2014 | May 1, 2017 |
| NCT02180997 | Completed | Phase 1 | Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin | July 2014 | March 2015 |
| NCT02206243 | Completed | Embozene® Microspheres for Prostatic Arterial Embolization in Patients With Symptomatic Benign Prostatic Hyperplasia | September 2014 | February 2019 | |
| NCT02239484 | Completed | Phase 1 | Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin | March 2014 | September 2014 |
| NCT04146103 | Completed | N/A | A Pumpkin Seed, Isoflavonoid and Cranberry Mix in LUTS/BPH | April 1, 2018 | March 31, 2019 |
| NCT02283684 | Completed | Phase 4 | GreenLight Laser Photoselective Vaporization of the Prostate vs Bipolar Transurethral Vaporization of the Prostate; RCT | September 2014 | February 2018 |
| NCT02303769 | Completed | Phase 3 | Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients With LUTS | March 2014 | October 2015 |
| NCT02313233 | Completed | N/A | Research on Benefit of Umooze as Add- on Therapy in Benign Prostatic Hyperplasia | December 2013 | May 2015 |
| NCT02326454 | Completed | Phase 2 | A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia | November 2014 | March 29, 2017 |
| NCT02346500 | Completed | Early Phase 1 | Ultrasound-Guided Photoselective Vaporization of the Prostate | December 2012 | November 26, 2016 |
| NCT02425800 | Completed | Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem Cells | July 28, 2015 | August 3, 2021 | |
| NCT02431754 | Completed | Phase 4 | A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS). | April 2015 | February 2016 |
| NCT02447367 | Completed | Phase 1 | Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers | July 2015 | December 2015 |
| NCT02494349 | Completed | Phase 1 | The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers. | August 2015 | December 2015 |
| NCT02509975 | Completed | N/A | Safety and Efficacy of OCL 503 in Prostate Artery Embolization | September 2015 | May 2018 |
| NCT02524236 | Completed | Early Phase 1 | Effect of 50 and 100 IU Doses of Botox A Toxin Injection in BPH Patients. | August 2015 | November 2016 |
| NCT04107896 | Completed | Phase 4 | Efficacy of Silodosin in the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH) | August 31, 2017 | August 31, 2018 |
| NCT02634489 | Completed | Phase 1 | EC905 Pharmacokinetic Profile Study | March 2009 | July 2009 |
| NCT02645890 | Completed | Phase 1 | Study to Compare the Safety and Pharmacokinetics of CKD-397 | November 2015 | December 2015 |
| NCT02667938 | Completed | Phase 3 | A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules | March 2015 | May 2016 |
| NCT03972371 | Completed | N/A | The ProVerum First in Man PROVE Study | May 13, 2019 | November 27, 2023 |
| NCT02757768 | Completed | Phase 4 | A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) | June 13, 2016 | September 11, 2018 |
| NCT03912766 | Completed | Serum Copeptin as a Predictor of the Risk of Hyponatremia After Transurethral Prostatectomy | February 1, 2016 | March 30, 2018 | |
| NCT03887871 | Completed | Phase 1 | Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers After Meal | March 11, 2019 | April 23, 2019 |
| NCT03887858 | Completed | Phase 1 | Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers | March 11, 2019 | May 7, 2019 |
| NCT03829904 | Completed | Phase 1/Phase 2 | The Effect of Traditional Chinese Medicine on Benign Prostatic Hyperplasia | March 6, 2019 | January 2, 2020 |
| NCT02869971 | Completed | Phase 3 | Prostatic Artery Embolization Versus Medical Treatment in Symptomatic Benign Prostatic Hyperplasia | August 2016 | March 25, 2022 |
| NCT02930889 | Completed | N/A | Prostate Artery Embolization (PAE) for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) | October 1, 2016 | October 31, 2020 |
| NCT02940392 | Completed | N/A | Rezum FIM Optimization Study | March 19, 2012 | May 19, 2017 |
| NCT02943070 | Completed | N/A | Rezum I Pilot Study for Benign Prostatic Hyperplasia | March 2012 | December 2018 |
| NCT03527589 | Completed | Embosphere® PROstate Post Market Study | August 16, 2018 | January 22, 2022 | |
| NCT02972268 | Completed | Phase 3 | Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH | February 1, 2016 | August 14, 2018 |
| NCT02977832 | Completed | N/A | Clinical Results of Odyliresin (Iresine Celosia) in Symptomatic Benign Prostatic Hyperplasia | January 2015 | September 2016 |
| NCT03194737 | Completed | N/A | Prostatic Urethral Lift in Subject With Acute Urinary Retention | March 24, 2018 | March 3, 2020 |
| NCT00037154 | Completed | Phase 3 | Saw Palmetto Extract in Benign Prostatic Hyperplasia | August 1999 | December 2002 |
| NCT00037141 | Completed | Phase 1/Phase 2 | Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate) | March 2002 | March 2004 |
| NCT00077012 | Completed | Phase 1/Phase 2 | Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia | March 2003 | May 2005 |
| NCT00111592 | Completed | N/A | Effectiveness of a Treatment Protocol for Lower Urinary Tract Symptoms in General Practice | August 2000 | December 2004 |
| NCT00127179 | Completed | Phase 3 | A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140) | January 1, 2004 | July 25, 2005 |
| NCT06380062 | Completed | Choline Metabolites in People With Prostate Cancer and Those With Benign Hyperplasia | January 12, 2012 | November 30, 2015 | |
| NCT06282731 | Completed | Early Phase 1 | The Changes of Urine Growth Factors Level | May 31, 2013 | April 27, 2017 |
| NCT00187616 | Completed | Questioning Patients About Adverse Medical Events | April 2002 | April 2003 | |
| NCT00194675 | Completed | Phase 4 | TRADE-Testosterone Replacement and Dutasteride Effectiveness | March 2005 | December 2010 |
| NCT03240939 | Completed | Phase 1 | Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil | March 27, 2017 | October 10, 2017 |
| NCT03075449 | Completed | Real World Data on Management of Male LUTS | May 19, 2016 | December 21, 2016 | |
| NCT03264482 | Completed | N/A | High Power Thulium Vaporization vs Transurethral Resection of the Prostate for Treatment of BPH | May 20, 2017 | December 1, 2020 |
| NCT03125863 | Completed | N/A | Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia | August 26, 2016 | July 31, 2017 |
| NCT03125889 | Completed | N/A | Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia II | April 10, 2017 | July 7, 2017 |
| NCT03144596 | Completed | Phase 4 | The Effects of α-adrenergic Receptor Antagonists on Choroid and Pupil | October 29, 2015 | November 19, 2016 |
| NCT03246880 | Completed | Phase 3 | Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients | September 2015 | May 2016 |
| NCT03167294 | Completed | N/A | AQUABEAM India Study for the Treatment of Benign Prostatic Hyperplasia | December 14, 2014 | April 27, 2017 |
| NCT03179670 | Completed | Interest of a Systematic Assessment of the Treatment of LUTS in the Management of BPH | June 15, 2017 | June 30, 2018 | |
| NCT05155891 | Enrolling by invitation | N/A | Investigation of Prostate Artery Embolization Compared to Holmium Laser Enucleation of Prostate | June 17, 2022 | January 1, 2027 |
| NCT06424912 | Not yet recruiting | N/A | Vivifi's Treatment, BPH Treatment Via Vasculature Anastomosis | August 30, 2024 | June 30, 2026 |
| NCT04245566 | Not yet recruiting | Phase 3 | Prostatic Artery Embolization vs. Pharmacotherapy for LUTS/BPH | September 2021 | December 2025 |
| NCT04529369 | Not yet recruiting | N/A | Middle Lobe Only Laser Vaporization or Total Prostate Vaporization of the Prostate, Prospective Cohort Study | October 2020 | October 2030 |
| NCT04807010 | Not yet recruiting | Phase 3 | PROARTE -PROstate ARTery to Reduce the Symptoms of Benign Prostatic Hyperplasia | August 1, 2021 | August 1, 2026 |
| NCT04979143 | Not yet recruiting | N/A | Moses Vaporization: Is Use of Moses 2.0 in Holmium Laser Ablation of the Prostate More Efficient | December 30, 2021 | December 31, 2024 |
| NCT05236634 | Not yet recruiting | N/A | (Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia | May 1, 2022 | June 30, 2024 |
| NCT05288621 | Not yet recruiting | N/A | Benigh Prosatic Hyperplasia/Lower Urinary Tract Symptoms | April 1, 2022 | December 30, 2024 |
| NCT05306145 | Not yet recruiting | N/A | Comparison of H-FIRE and TURP in Treating Benign Prostatic Hyperplasia | July 1, 2022 | October 1, 2028 |
| NCT05393921 | Not yet recruiting | Phase 4 | The Combined Effect of Intravesical Botox Injections and HoLEP Surgery in Treating Benign Prostatic Hyperplasia and Overactive Bladder | November 30, 2024 | July 2027 |
| NCT05567666 | Not yet recruiting | N/A | Optilume BPH Catheter System in Benign Prostatic Hyperplasia (BPH) | November 15, 2022 | December 31, 2024 |
| NCT05576311 | Not yet recruiting | Codesign of an Optical Device to Measure Urine Flow and Volume | November 1, 2022 | February 28, 2023 | |
| NCT05784558 | Not yet recruiting | RELIEF Study: Real-world Evaluation of LUTS Interventions and Patient Experience During Follow-up | April 3, 2023 | December 31, 2030 | |
| NCT05784909 | Not yet recruiting | N/A | Outcomes of Water Vapor Thermal Therapy (REZUM) in Management of Symptomatic Patients With Benign Prostatic Enlargement | April 1, 2023 | May 1, 2024 |
| NCT05913466 | Not yet recruiting | N/A | Intraprostatic Injection of Tranexamic Acid Decrease Blood Loss During Monopolar TURP | June 20, 2023 | June 20, 2024 |
| NCT06212453 | Not yet recruiting | Phase 2 | Evaluation of the Functional Outcomes After Bilateral, 3D Ultrasound-guided Focal Thermal Ablation of the Prostate Transition Zone, in Patients With Benign Prostatic Hyperplasia-related Obstruction | April 2024 | August 2026 |
| NCT06275256 | Not yet recruiting | Phase 3 | Outcomes of MIST for BPH: A Single-Institution Prospective Study | March 2024 | March 2025 |
| NCT05001477 | Recruiting | Customized TULSA-PRO Ablation Registry | October 27, 2021 | October 2061 | |
| NCT05116592 | Recruiting | The Risk Factor and Outcome of Transient Incontinence After Prostate Enucleation Surgery | April 1, 2020 | June 2, 2024 | |
| NCT04627701 | Recruiting | N/A | Omega Study: Evaluation of the Safety and Efficacy of the Omega System for the Treatment of BPH | July 23, 2023 | December 2024 |
| NCT04726748 | Recruiting | Economic Evaluation of Prostatic Urethral Lift | April 8, 2021 | June 2026 | |
| NCT06181175 | Recruiting | N/A | Treatment of BPH With CO2 Serenoa +PEA as Monotherapy or in Combination With Tamsulosin: ProSeRePEA Trial | October 1, 2021 | April 30, 2025 |
| NCT04879940 | Recruiting | Phase 2 | Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization | February 23, 2022 | August 1, 2024 |
| NCT06157164 | Recruiting | IIT-2022-Simultaneous Urolift™ and Median Lobe Enucleation | February 6, 2023 | February 6, 2025 | |
| NCT04807296 | Recruiting | N/A | Thulium Fiber Laser Enucleation of the Prostate (TFLEP) vs HoLEP With Moses Technology (m-HoLEP) | September 8, 2021 | September 2024 |
| NCT05757687 | Recruiting | N/A | Evaluation of the Safety, Tolerability, and Efficacy of the Omega System for the Treatment of LUTS Due to BPH | February 7, 2023 | December 1, 2024 |
| NCT04084938 | Recruiting | N/A | Artery Embolization vs Operation of Benign Prostate Hyperplasia | September 1, 2019 | December 31, 2027 |
| NCT05678452 | Recruiting | N/A | Comparative Study Between Safety and Effectiveness of High Versus Low Power HOLEP | January 1, 2022 | September 1, 2024 |
| NCT05585450 | Recruiting | N/A | Effect of Electroacupuncture on Benign Prostatic Hyperplasia | March 9, 2023 | December 30, 2025 |
| NCT06266000 | Recruiting | Phase 4 | Comparison of 2 Extracts of Saw Palmetto Versus Placebo on BPH Symptoms | March 1, 2024 | March 1, 2025 |
| NCT04185441 | Recruiting | Phase 3 | Efficacy and Safety of Tanzânia Association in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia | March 14, 2021 | May 2023 |
| NCT05574244 | Recruiting | N/A | Comparison of Functional Outcomes of Ejaculation-preserving Partial Trans Urethral Resection of the Prostate With Complete Trans Urethral Resection of the Prostate for Benign Prostatic Obstruction | September 29, 2022 | April 15, 2027 |
| NCT05543200 | Recruiting | BPH Global Registry | March 13, 2023 | March 2027 | |
| NCT05400980 | Recruiting | N/A | The Expander-2 Trial: A Randomized Study to Evaluate the Safety and Efficacy of the Urocross(TM) Expander System and Retrieval Sheath | July 5, 2022 | January 2027 |
| NCT06225479 | Recruiting | N/A | PRescription Exercise for Older Men With Urinary Disease | January 3, 2024 | April 1, 2026 |
| NCT05292235 | Recruiting | Perioperative Parameter and Treatment Outcomes of Surgical Treatment for Benign Prostate Hyperplasia in Hong Kong | April 1, 2022 | July 31, 2032 | |
| NCT03297281 | Recruiting | N/A | Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP) | October 30, 2017 | May 31, 2026 |
| NCT05240001 | Recruiting | N/A | Thulium Fiber Laser (TFL) vs Holmium MOSES for Treatment of Benign Prostatic Hyperplasia (BPH) | April 20, 2022 | December 2025 |
| NCT04288427 | Recruiting | N/A | 5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy | September 25, 2020 | November 30, 2025 |
| NCT06312722 | Recruiting | N/A | Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study | February 7, 2024 | February 7, 2031 |
| NCT04309695 | Recruiting | N/A | The Zenflow Spring System Safety and Performance Study (ZEST CAN) | February 9, 2021 | January 1, 2026 |
| NCT04338776 | Recruiting | N/A | Comparing UroLift Experience Against Rezūm | January 22, 2021 | December 2025 |
| NCT06182189 | Recruiting | Protocollo N 2014 - Benign Prostatic Hyperplasia | December 1, 2014 | December 31, 2034 | |
| NCT05157529 | Recruiting | N/A | AQUABEAM® Robotic System and Ultrasound Accessories | February 16, 2023 | December 30, 2024 |
| NCT03521648 | Recruiting | Database for the Assessment of Efficacy and Safety of BPH Treatment | July 7, 2017 | December 1, 2027 | |
| NCT05898932 | Recruiting | Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes | June 1, 2023 | August 2026 | |
| NCT05884580 | Recruiting | N/A | Neuflo System for the Treatment of BPH | December 2023 | December 2024 |
| NCT06051942 | Recruiting | N/A | PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs | November 22, 2022 | May 2026 |
| NCT04997369 | Suspended | N/A | Catheterless Water Vapor Therapy for the Treatment of BPH | October 13, 2021 | July 2027 |
| NCT05148156 | Suspended | N/A | Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer. | December 15, 2021 | December 2024 |
| NCT04340934 | Terminated | N/A | The Use of REZUM System in Chinese Male Patients With LUTS Secondary to Benign Prostate Enlargement | May 13, 2020 | January 29, 2021 |
| NCT03938194 | Terminated | N/A | Waterjet Prostate Ablation | April 25, 2019 | October 21, 2021 |
| NCT02019030 | Terminated | Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode | December 2013 | January 3, 2017 | |
| NCT01931605 | Terminated | Phase 3 | Results of Selective Prostatic Arterial Embolization in Patients With Indwelling Urinary Catheter Due to Benign Prostatic Hyperplasia Refractory to Medical Treatment. | May 2014 | March 2015 |
| NCT01830829 | Terminated | Phase 3 | JALYN for Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) | April 2013 | October 2014 |
| NCT01789840 | Terminated | N/A | Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia | July 2013 | December 2017 |
| NCT01534351 | Terminated | Phase 3 | Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2) | August 1, 2013 | November 18, 2013 |
| NCT01097707 | Terminated | Phase 2 | A Study in Men With Benign Prostatic Hyperplasia | April 2010 | October 2011 |
| NCT00501371 | Terminated | Phase 3 | MCS in Treating Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia | July 2007 | October 2009 |
| NCT00435448 | Terminated | Phase 3 | Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia | June 2005 | December 2006 |
| NCT00431626 | Terminated | Phase 3 | A Clinical Trial Comparing Laser TURP With and Without Dutasteride. | October 2006 | April 2009 |
| NCT00237536 | Terminated | Phase 2 | Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia | June 2005 | August 2006 |
| NCT00064649 | Terminated | Phase 3 | Minimally Invasive Surgical Therapy for BPH | April 2004 | June 2006 |
| NCT00169767 | Terminated | Holmium Laser Ablation of the Prostate (HoLAP) Versus KTP Laser Vaporization of the Prostate | May 2005 | April 2008 | |
| NCT00421421 | Terminated | Phase 4 | Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter | March 2007 | |
| NCT03297398 | Terminated | Phase 2 | Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) | February 21, 2018 | June 10, 2019 |
| NCT03062111 | Terminated | N/A | Laser Enucleation of Prostate (LEP) Versus Transurethral Resection of Prostate (TURP) | October 23, 2017 | January 15, 2021 |
| NCT02962674 | Terminated | N/A | To Evaluate the Safety and Performance of the ProstaCare Water Electrolysis System in Relieving Symptoms of BPH. | September 19, 2016 | November 20, 2020 |
| NCT02918227 | Terminated | N/A | Exploration of Ejaculation Changing Mechanism After Surgery for Benign Prostatic Hyperplasia | December 8, 2016 | June 11, 2018 |
| NCT00954889 | Unknown status | N/A | Clinical Effect and Safety of Tamsulosin 0.4mg in Patients With LUTS/BPH Refractory to Tamsulosin 0.2mg | August 2009 | |
| NCT05094947 | Unknown status | N/A | Intermittent Catheterization Versus Trial Without Catheter | August 3, 2021 | May 2022 |
| NCT04853914 | Unknown status | N/A | Evaluation of the Safety of the Treatment of Benign Prostatic Hyperplasia by High Intensity Focused Ultrasound. | September 13, 2021 | June 2022 |
| NCT01314456 | Unknown status | N/A | 3D Recording of a Trans-rectal Prostate Biopsy | March 2011 | December 2011 |
| NCT04802252 | Unknown status | A Diagnostic Study of Abnormal Acoustic Waves in Modern Pulse in Benign Prostatic Hyperplasia | March 1, 2021 | June 1, 2022 | |
| NCT04912349 | Unknown status | N/A | Comparison of TUSP Versus TURP for Treatment of Benign Prostatic Hyperplasia in a Small Prostate Volume | July 1, 2020 | June 30, 2022 |
| NCT03583034 | Unknown status | Outcomes and Complications of Holmium Laser Enucleation of the Prostate in Expert Hands | June 18, 2018 | June 18, 2020 | |
| NCT01073241 | Unknown status | N/A | Transurethral Ventral Wall of Urethra-preserving Enucleation of Prostate | March 2010 | February 2012 |
| NCT01404637 | Unknown status | N/A | Effects of Tamsulosin 0.4mg on Clinical Outcomes in Korean Men With Severe Symptomatic Benign Prostatic Hyperplasia (BPH) | July 2011 | October 2013 |
| NCT04658056 | Unknown status | UK Post-market Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue | January 2021 | February 2022 | |
| NCT04566588 | Unknown status | N/A | Early Apical Release vs Classic Holmium Laser Enucleation of the Prostate: Randomized Controlled Trial Comparing Post-Operative Incontinence Rates and Surgical Outcomes | June 25, 2020 | May 2022 |
| NCT05077852 | Unknown status | Intravesical Prostatic Protrusion Mimicking Urothelial Cell Carcinoma of the Bladder | December 12, 2021 | December 30, 2022 | |
| NCT00690950 | Unknown status | Phase 4 | A Study to Determine the Improvement of the Symptoms of Benign Prostatic Hyperplasia (BPH) When Switching Subjects From Proscar to Avodart | May 2008 | |
| NCT04352257 | Unknown status | Bladder and Prostate Sonomorphology in Patients With Symptomatic Benign Prostatic Hyperplasia | April 1, 2019 | April 1, 2021 | |
| NCT05200065 | Unknown status | N/A | Thulium Laser Versus Bipolar Enucleation of the Prostate | January 1, 2021 | October 31, 2022 |
| NCT02869061 | Unknown status | Phase 1/Phase 2 | Effectiveness and Safety of Adipose-derived Regenerative Cells for Reduction of Risk of Bladder Neck Contracture | January 2016 | December 2018 |
| NCT05274672 | Unknown status | Phase 4 | Role of Prophylactic Postoperative Antibiotics in HoLEP | March 1, 2022 | June 1, 2023 |
| NCT00130767 | Unknown status | Phase 4 | Kinetics of the Finasteride Prostate Induced Apoptosis | December 2004 | |
| NCT04267445 | Unknown status | Evaluate the Safety and Effectiveness of Using Echogenic Embolic Agent for Embolization of Prostate Artery for Treatment of Men With BPH (PAE CEUS) | March 2020 | March 2023 | |
| NCT02167009 | Unknown status | N/A | Benign Prostatic Hyperplasia and Prostate Size Greater Than 90 Grams | December 2014 | May 2020 |
| NCT00274417 | Unknown status | N/A | Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP) | January 2006 | May 2009 |
| NCT00381108 | Unknown status | Phase 1 | Study of the Effects of Pomegranate Tablets on Enlarged Prostates | September 2005 | June 2010 |
| NCT05415748 | Unknown status | Phase 4 | Deprescribing Tamsulosin in Older Men | September 18, 2021 | June 2022 |
| NCT03595735 | Unknown status | N/A | The Zenflow Spring System Safety, Performance and Effectiveness Study | June 21, 2018 | March 30, 2024 |
| NCT00468026 | Unknown status | Phase 1 | Evaluation of the ProstaPlant Prostate Stent Insertion in Ex Vivo Human Prostate | ||
| NCT03479359 | Unknown status | Learning Curve of Digital Rectal Examination for Prostate Cancer Among Internship | February 26, 2018 | February 26, 2019 | |
| NCT03503721 | Unknown status | N/A | Bipolar Transurethral Enucleation (BipolEP) vs Bipolar Transurethral Resection of the Prostate | January 18, 2018 | June 18, 2021 |
| NCT04236687 | Unknown status | N/A | Prostate Artery Embolization Compared to Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia | February 1, 2020 | February 1, 2022 |
| NCT02279615 | Unknown status | Phase 4 | Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia. | December 2021 | December 2022 |
| NCT02293759 | Unknown status | Phase 4 | Trial of HoLEP vs. PVP in Treating BPH in Patients With Bleeding Tendency | October 2014 | September 2016 |
| NCT04044573 | Unknown status | N/A | Focal Laser Ablation for Benign Prostatic Hyperplasia | May 5, 2018 | April 5, 2023 |
| NCT02862483 | Unknown status | Phase 3 | The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile Dysfunction | March 2016 | March 2017 |
| NCT03768765 | Unknown status | Duration of Medication Therapy and Outcomes After Holmium Laser Prostate Surgery for Patients With Benign Prostatic Hyperplasia (BPH) | November 15, 2018 | December 2022 | |
| NCT03577236 | Unknown status | N/A | The Zenflow Spring System EU Safety and Performance Study | January 16, 2019 | May 30, 2024 |
| NCT03959917 | Unknown status | TURP; Complications and Outpatient Care | May 15, 2019 | September 30, 2020 | |
| NCT02786290 | Unknown status | N/A | The Zenflow Spring System Feasibility and Safety Study | April 2016 | January 2020 |
| NCT00400894 | Unknown status | Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma | September 2005 | September 2006 | |
| NCT03157726 | Unknown status | N/A | Transurethral Plasmakinetic Enucleation of Prostate Versus Transurethral Resection of Prostate | October 11, 2017 | June 1, 2021 |
| NCT03109925 | Unknown status | Phase 2 | Use of a Novel Radiopaque Embolic Agent in Prostatic Artery Embolisation for Symptomatic Benign Prostatic Enlargement | June 2, 2017 | June 29, 2021 |
| NCT04826887 | Unknown status | SOLTIVE™ Laser Enucleation for Treatment of Benign Prostatic Hyperplasia | April 29, 2021 | December 31, 2023 | |
| NCT01351987 | Unknown status | An Observational Study of Dutasteride and Alpha-blocker Combination Therapy in Men With Symptomatic Benign Prostatic Hyperplasia and PSA Level Over 4 ng/mL | December 2010 | December 2013 | |
| NCT04563221 | Withdrawn | N/A | Prostatic Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH) | May 1, 2022 | December 1, 2024 |
| NCT01520441 | Withdrawn | Early Phase 1 | BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH) | March 2011 | March 2014 |
| NCT02822963 | Withdrawn | Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate | March 2016 | August 2016 | |
| NCT02566551 | Withdrawn | N/A | Prospective Controlled Randomized Study of PAE vs TURP for BPH Treatment. | October 2015 | May 2019 |
| NCT03043222 | Withdrawn | N/A | Innovative Minimally Invasive Options in Treatment of Urinary Problems Related to Prostate Enlargement (BPH) in Men | March 1, 2018 | June 1, 2019 |
| NCT00687388 | Withdrawn | Phase 4 | The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic Hyperplasia | May 2008 | |
| NCT02679430 | Withdrawn | N/A | Analysis of Prostatic Arterial Embolization for Benign Prostatic Hyperplasia Using Embosphere Microspheres | May 2013 | December 31, 2015 |
| NCT01967251 | Withdrawn | Phase 2 | Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction | September 2015 | September 2016 |
| NCT04243824 | Withdrawn | Early Phase 1 | Ga-68 MAA Distribution in PAE Patients | May 2021 | May 2022 |
| NCT00564460 | Withdrawn | Phase 3 | On Label, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoing Transurethral Resection of the Prostate (TURP) | February 2008 | February 2011 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0008711